SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
opioids
opioids
Finance
Purdue Pharma makes new offer to settle lawsuits over Oxycontin opioid crisis, and it includes up to $7 billion cash from the Sacklers
By
Geoff Mulvihill
and
The Associated Press
March 19, 2025
Politics
How do Mexico, Canada, and China affect fentanyl flowing into the U.S.?
By
The Associated Press
and
Jesse Bedayn
February 4, 2025
Health
Purdue Pharma and Sackler family to pay $7.4 billion in revised settlement of lawsuits over OxyContin opioid toll
By
Geoff Mulvihill
and
The Associated Press
January 24, 2025
Health
Ohio Supreme Court says counties can’t sue pharmacy chains in decision that could overturn a $650 million opioid judgment
By
Julie Carr Smyth
and
The Associated Press
December 11, 2024
Health
Arkansas is suing pharmacy benefit managers Express Scripts and Optum, accusing them of fueling the state’s opioid crisis
By
Andrew DeMillo
and
The Associated Press
June 25, 2024
Health
California partners with pharma firm on generic Narcan amid opioid crisis
By
Adam Beam
and
The Associated Press
April 29, 2024
Health
OxyContin marketer and opioid maker announce $500m in settlements to avoid trials on their responsibility for crisis
By
Geoff Mulvihill
and
The Associated Press
February 2, 2024
Health
EBay will pay $59m settlement over pill presses sold on the site—the kind used to make counterfeit pills laced with fentanyl
By
Lindsay Whitehurst
and
The Associated Press
February 1, 2024
Finance
OxyContin-maker Purdue Pharma heads to Supreme Court in case over whether $6bn payoff can shield Sackler owners from future lawsuits
By
Mark Sherman
and
The Associated Press
December 4, 2023
Health
White patients are more likely than Black patients to be prescribed opioids for pain in US emergency departments. Here’s why it matters
By
Trevor Thompson
,
Sofia Stathi
and
The Conversation
October 29, 2023
Retail
Rite Aid’s years of red ink and opioid losses prompt pharmacy giant to file for bankruptcy
By
Tom Murphy
,
Elaine Kurtenbach
and
The Associated Press
October 17, 2023
Health
The opioid crisis is so bad that prosecutors are starting to charge drug addict parents with their kids’ Fentanyl overdoses
By
Olga R. Rodriguez
and
The Associated Press
September 8, 2023
Leadership
Biden’s DOJ doesn’t think the Sackler family should get released from opioid liability and the Supreme Court agrees—for now
By
Mark Sherman
and
The Associated Press
August 10, 2023
Features
60% of Americans battling drug or alcohol addictions also have jobs. Here are the professions with the highest rates of substance-use disorder
By
Erika Fry
August 4, 2023
Health
Secret limits to stop ‘suspicious’ Xanax and Adderall orders are forcing some legitimate patients to scramble
By
Ike Swetlitz
and
Bloomberg
April 3, 2023
Most Popular
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Success
Be careful boomers, your Gen Z coworker may be recording you — 9-to-5s aren’t just about climbing the ladder, they’re...
By
Jessica Coacci
Success
This Stanford computer science professor went to written exams 2 years ago because of AI. He says his students insisted...
By
Nick Lichtenberg